NSE filing, NSE: PONNIERODE. Summary written from the filing by ALFA Finder's alert engine.
Ponni Sugars (Erode) Ltd: key numbers
- Share price
- ₹329.10
- Market cap
- ₹283.0 Cr
- Revenue (annual)
- ₹415.0 Cr
- Net profit (annual)
- ₹48.03 Cr
- P/E (TTM)
- 5.0×Sector 26.2×
- Promoter holding
- 50.84%+3.50% QoQ
- FII holding
- 5.91%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ponni Sugars (Erode) Ltd
All →Ponni Sugars (Erode) Q2 FY27 Results: Net Profit ₹21.7 Cr, Up 48.6% YoY
Ponni Sugars (Erode) Ltd reported revenue from operations of ₹159.6 Cr (+40.4% YoY) and net profit of ₹21.7 Cr (+48.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹21.7 Cr · +48.6% YoY
Ponni Sugars (Erode) Promoter Reclassification
TSIPL, a promoter, acquired over 20% stake in DIPL and UILCPL, causing their inclusion in the promoter group of Ponni Sugars (Erode) Ltd.
Ponni Sugars (Erode) Capital Structure Change
Non-promoter ACIF-1 sold its entire 5,00,000-share (5.8150%) Ponni Sugars stake via open market trades in October 2026, exiting to nil.
Ponni Sugars (Erode) Board Meeting Date
Ponni Sugars (Erode) Ltd will hold a board meeting on October 23, 2026, to consider and approve the unaudited financial results for the September 2026 quarter.
Ponni Sugars (Erode) Promoter Reclassification
Ponni Sugars (Erode) Ltd notified that two entities, DIPL and UILCPL, will join the Promoter Group following an acquisition by Promoter entity TSIPL.
Ponni Sugars (Erode) Capital Structure Change
ACIF-1 sold a 3.65% stake in Ponni Sugars (Erode) Limited through open market operations. The non-promoter entity's holding reduced from 9.46% to 5.82%.
Other other announcement announcements
All →Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals reported no deviation in utilising the Rs 95 Crore raised via a preferential warrant issue for the quarter ended September 30, 2026. Audit Committee reviewed the statement and the Board took it on record.
- Value
- ₹95.00 Cr
NIIT Learning Systems Other Announcement
NIIT Learning Systems board recommended appointing Price Waterhouse Chartered Accountants LLP as statutory auditor for five years from the 25th AGM. The incumbent S. R. Batliboi firm completes its second term.
- Execution
- Five consecutive years, from the 25th AGM (2027) until the 30th AGM (2032)
Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals appointed Talati and Talati LLP as Statutory Auditor for a 60-month term, effective 29 October 2026. The appointment was approved at the board meeting held the same day.
- Execution
- 60 months
Magson Retail & Distribution Other Announcement
Magson Retail submitted its Regulation 76 Reconciliation of Share Capital Audit Report for the quarter ended 30 September 2026. The report shows a 9,15,940 share difference between issued and listed capital, pending exchange listing approval.
Ekennis Software Service Other Announcement
Ekennis Software declared Regulation 23 related party transaction rules non-applicable for H1 FY27, as its paid-up capital and net worth are below SME thresholds. A CA certificate confirms the figures.
Shri Gang Industries and Allied Products Other Announcement
Shri Gang Industries filed its quarterly shareholding pattern dated 23 October 2026. The filing notes pledges, a warrant conversion, and a deceased promoter's shares moved to a nominee.